HGC Investment Management’s Liminatus Pharma, Inc. Warrants LIMNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$300 Buy
+1,250
New +$300 ﹤0.01% 98